171 related articles for article (PubMed ID: 38127137)
1. A simple tool for evaluation of inflammation in psoriasis: Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio as markers in psoriasis patients and related murine models of psoriasis-like skin disease.
Kommoss KS; Bieler T; Ringen J; Lehmann A; Mihalceanu S; Hobohm L; Keller K; Brand A; Fischer B; Kramer D; Wild J; Waisman A; Enk A; Schäkel K; Heikenwälder M; Karbach S
J Mol Med (Berl); 2024 Feb; 102(2):247-255. PubMed ID: 38127137
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and mean platelet volume in Japanese patients with psoriasis and psoriatic arthritis: Response to therapy with biologics.
Asahina A; Kubo N; Umezawa Y; Honda H; Yanaba K; Nakagawa H
J Dermatol; 2017 Oct; 44(10):1112-1121. PubMed ID: 28493493
[TBL] [Abstract][Full Text] [Related]
3. Assessments of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in Korean patients with psoriasis vulgaris and psoriatic arthritis.
Kim DS; Shin D; Lee MS; Kim HJ; Kim DY; Kim SM; Lee MG
J Dermatol; 2016 Mar; 43(3):305-10. PubMed ID: 26381893
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the inflammatory parameters as potential biomarkers of systemic inflammation extent and the disease severity in psoriasis patients.
Zhang Y; Qian H; Kuang YH; Wang Y; Chen WQ; Zhu W
Arch Dermatol Res; 2024 May; 316(6):229. PubMed ID: 38787405
[TBL] [Abstract][Full Text] [Related]
5. Role of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, Mean Platelet Volume in Egyptian Patients with Psoriasis Vulgaris.
Hammad R; Hamdino M; El-Nasser AM
Egypt J Immunol; 2020 Jan; 27(1):157-168. PubMed ID: 33180397
[TBL] [Abstract][Full Text] [Related]
6. The effect of IL17 and IL23 inhibitors on hematological parameters and C-reactive protein in psoriasis patients.
Esen M
Cutan Ocul Toxicol; 2024 Mar; 43(1):38-45. PubMed ID: 37897439
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Psoriasis Area and Severity Index Thresholds as Proxies for Systemic Inflammation on an Individual Patient Level.
Hoffmann JHO; Enk AH
Dermatology; 2022; 238(4):609-614. PubMed ID: 34852349
[TBL] [Abstract][Full Text] [Related]
8. The Relationship of Hematological Parameters and C-reactive Protein (CRP) With Disease Presence, Severity, and Response to Systemic Therapy in Patients With Psoriasis.
Şener G; İnan Yuksel E; Gökdeniz O; Karaman K; Canat HD
Cureus; 2023 Aug; 15(8):e43790. PubMed ID: 37731441
[TBL] [Abstract][Full Text] [Related]
9. Is there any Correlation between Red Cell Distribution Width, Mean Platelet Volume Neutrophil Count, Lymphocyte Count, and Psoriasis Area Severity Index in Patients Under Treatment for Psoriasis?
Balevi A; Olmuşçelik O; Ustuner P; Özdemir M
Acta Dermatovenerol Croat; 2018 Oct; 26(3):199-205. PubMed ID: 30390720
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in psoriasis: a systematic review and meta-analysis.
Ye JH; Zhang Y; Naidoo K; Ye S
Arch Dermatol Res; 2024 Feb; 316(3):85. PubMed ID: 38329632
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil/platelet to lymphocyte ratio in monitoring of response to TNF-α inhibitors in psoriatic patients.
Najar Nobari N; Shahidi Dadras M; Nasiri S; Abdollahimajd F; Gheisari M
Dermatol Ther; 2020 Jul; 33(4):e13457. PubMed ID: 32319132
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and other hematological parameters in psoriasis patients.
Wang WM; Wu C; Gao YM; Li F; Yu XL; Jin HZ
BMC Immunol; 2021 Sep; 22(1):64. PubMed ID: 34565327
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Chronic Plaque Psoriasis.
Mondal S; Guha S; Saha A; Ghoshal L; Bandyopadhyay D
Indian J Dermatol; 2022; 67(4):477. PubMed ID: 36578726
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in Turkish patients with chronic plaque psoriasis.
Polat M; Bugdayci G; Kaya H; Oğuzman H
Acta Dermatovenerol Alp Pannonica Adriat; 2017 Dec; 26(4):97-100. PubMed ID: 29264899
[TBL] [Abstract][Full Text] [Related]
15. Associations of novel complete blood count-derived inflammatory markers with psoriasis: a systematic review and meta-analysis.
Liu YC; Chuang SH; Chen YP; Shih YH
Arch Dermatol Res; 2024 May; 316(6):228. PubMed ID: 38787437
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil-to-lymphocyte ratio may predict subclinical atherosclerosis in patients with psoriasis.
Yurtdaş M; Yaylali YT; Kaya Y; Ozdemir M; Ozkan I; Aladağ N
Echocardiography; 2014 Oct; 31(9):1095-104. PubMed ID: 24447343
[TBL] [Abstract][Full Text] [Related]
17. Relationship between generalized epileptic seizure and neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and neutrophil mediated inflammation.
Güneş M; Büyükgöl H
Int J Neurosci; 2020 Nov; 130(11):1095-1100. PubMed ID: 31983256
[No Abstract] [Full Text] [Related]
18. Could Blood Cell-Based Inflammatory Markers Be Used to Monitor Response to Biologic Therapy in Psoriasis?
Kulakli S; Oguz ID; Aksan B
Sisli Etfal Hastan Tip Bul; 2023; 57(4):536-542. PubMed ID: 38268655
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Monocyte-to-Lymphocyte Ratio (MLR) as Biomarkers in Diagnosis Evaluation of Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective, Observational Study.
Cai C; Zeng W; Wang H; Ren S
Int J Chron Obstruct Pulmon Dis; 2024; 19():933-943. PubMed ID: 38646605
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in evaluation of inflammation in non-dialysis patients with end-stage renal disease (ESRD).
Li P; Xia C; Liu P; Peng Z; Huang H; Wu J; He Z
BMC Nephrol; 2020 Nov; 21(1):511. PubMed ID: 33238906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
